Related Experiment Videos
Peripheral neuropathy in systemic lupus erythematosus.
Summary
Peripheral neuropathy (PN) affects nearly 28% of systemic lupus erythematosus patients, often impacting sensory nerves. Sural nerve conduction may indicate disease activity.
Area of Science:
- Neurology
- Rheumatology
- Immunology
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with variable clinical manifestations.
- Clinically apparent peripheral neuropathy (PN) in SLE ranges from 2% to 18% prevalence.
- Electrodiagnostic criteria for PN prevalence in SLE require further investigation.
Purpose of the Study:
- To determine the prevalence of peripheral neuropathy (PN) in systemic lupus erythematosus (SLE) using electrodiagnostic criteria.
- To explore correlations between PN and SLE disease activity, renal involvement, and serum immune markers.
- To identify sensitive electrophysiological indicators for monitoring SLE-related PN.
Main Methods:
- Prospective case-control study involving 54 SLE patients and 30 controls.
- Standard nerve conduction studies (NCS) of median, ulnar, peroneal, tibial, and sural nerves.
- PN defined by abnormal NCS values affecting at least two nerves.
Main Results:
- PN was diagnosed in 27.8% of SLE patients, with only 4 symptomatic cases.
- A significant correlation was found between PN and anti-SM antibody presence.
- Sensory nerves, particularly the sural nerve, were more affected than motor nerves, with reduced action potential amplitudes being a key finding.
Conclusions:
- The electrodiagnostically determined prevalence of PN in SLE is higher than previously reported clinically apparent cases.
- Anti-SM antibody positivity is associated with PN in SLE.
- Reduced sural sensory nerve action potential amplitude may serve as a sensitive marker for monitoring SLE activity and PN.